Parathyroid cancer secondary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Parathyroid cancer}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Secondary Prevention== * Germline DNA analysis for HRPT2/CDC73 is recommended among patients with para...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategy recommended following parathyroid cancer is germline DNA analysis for HRPT2/CDC73. | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
* Germline DNA analysis for HRPT2/CDC73 is recommended among patients with parathyroid cancer, as early detection can benefit relatives and offsprings. | * Germline DNA analysis for HRPT2/CDC73 is recommended among patients with parathyroid cancer, as early detection can benefit relatives and offsprings. | ||
==Reference== | ==Reference== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 15:28, 28 December 2015
|
Parathyroid cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parathyroid cancer secondary prevention On the Web |
|
American Roentgen Ray Society Images of Parathyroid cancer secondary prevention |
|
Risk calculators and risk factors for Parathyroid cancer secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Secondary prevention strategy recommended following parathyroid cancer is germline DNA analysis for HRPT2/CDC73.
Secondary Prevention
- Germline DNA analysis for HRPT2/CDC73 is recommended among patients with parathyroid cancer, as early detection can benefit relatives and offsprings.